NEW OR RETURNING USERS: SIGN IN  |   UPDATE PROFILE  |   CME/CE TRACKER    



  

Gastroenterology

On-Demand Webcast 2
                      Expert Perspectives on Hepatitis B
                      Virus and the Infected Patient

This CME/CE activity has reached its termination date and no longer offers continuing education credit. Please note that expired CME/CE activities may not contain the most up-to-date information available.

Click here to view our current activities in Gastroenterology.

Expert Perspectives on Hepatitis B
Virus and the Infected Patient
On-Demand Webcast 2

Dear Colleague,

Left unhalted, replication of hepatitis B virus (HBV) can have serious consequences, including cirrhosis or hepatocellular carcinoma. Persons with risk factors for this highly contagious virus must be screened, and those who are infected should be thoroughly evaluated to determine candidacy for treatment.

If you missed the CME/CE audioconference held on November 8, 2006, here is your second chance to participate in this outstanding educational activity. This 1-hour webcast will provide you with a solid overview of the virus, including its structure and replication, genotypes, and natural history and talk about how to make optimal use of available screening and diagnostic tools, as well as how to apply recently updated management guidelines to determine which patients are candidates for treatment.

I hope you find this activity helpful in applying current knowledge of hepatitis B and its management in the care of your patients.

Sincerely,

CO-CHAIR
Adrian M. Di Bisceglie, MD, FACP
Professor of Internal Medicine
Chief of Hepatology
Saint Louis University School of Medicine
St. Louis, Missouri




Adrian M. Di Bisceglie, MD, FACP, and Robert G. Gish, MD, co-chairs of Advanced Certificate Program II: Management of Chronic Hepatitis B, alternate to help develop content for the audioconferences. This audioconference was developed by Dr. Adrian M. Di Bisceglie and Dr. Michael W. Fried.

FACULTY
Michael W. Fried, MD
Professor of Medicine
Director of Hepatology
Division of Gastroenterology and Hepatology
University of North Carolina
Chapel Hill, North Carolina
top

TARGET AUDIENCE
This activity is designed for gastroenterologists, hepatologists, and other clinicians who care for patients with hepatitis B infection or those at increased risk for acquiring the infection.

ACTIVITY GOAL
The goal of Expert Perspectives on Hepatitis B Virus and the Infected Patient is to examine current knowledge about the hepatitis B virus (HBV) and current strategies for diagnosing and evaluating infected patients.

LEARNING OBJECTIVES
  • Describe the virologic structure and life cycle of the hepatitis B virus, based on the current state of knowledge in this field.

  • For patients with risk factors for HBV infection, employ serologic screening tests to successfully identify those who are infected.

  • For patients infected with HBV, make the best use of available diagnostic tests and liver biopsy to distinguish those who are candidates for treatment from those who require ongoing monitoring without treatment, based on current guidelines.
top

CME INFORMATION—PHYSICIANS

Statement of Accreditation
Projects In Knowledge is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation
Projects In Knowledge designates this educational activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This activity is planned and implemented as an independent CME activity in accordance with the ACCME Essential Areas and Policies.

CME INFORMATION—PHYSICIAN ASSISTANTS
Projects In Knowledge will issue a certificate of participation for each course the participant completes. Please check with your organization and/or society for reciprocity.

CE INFORMATION—NURSES
This activity has been approved by the American Association of Critical-Care Nurses (AACN) for a maximum of 1.0 contact hour. Provider #00012705.

Contract for Mutual Responsibility in CME/CE

Projects In Knowledge has developed the contract to demonstrate our commitment to providing the highest quality professional education to clinicians, and to help clinicians set educational goals to challenge and enhance their learning experience.
For more information on the contract, click here.

top

DISCLOSURE INFORMATION
The Disclosure Policy of Projects In Knowledge requires that presenters comply with the Standards for Commercial Support. All faculty are required to disclose any personal interest or relationship they or their spouse/partner have with the supporters of this activity or any commercial interest that is discussed in their presentation. Any discussions of unlabeled/unapproved uses of drugs or devices will also be disclosed in the course materials.

For complete prescribing information on the products discussed during this CME/CE activity, please see your current Physicians' Desk Reference (PDR).

Adrian M. Di Bisceglie, MD, FACP, has received grant/research support from Gilead Sciences, Inc, Idenix Pharmaceuticals, Roche Pharmaceuticals, SciClone Pharmaceuticals, and Vertex Pharmaceuticals Inc; is a consultant for Abbott Laboratories, Bristol-Myers Squibb Company, Chiron Corporation, Metabasis Therapeutics, and SciClone Pharmaceuticals; is on the speakers bureau of Bristol-Myers Squibb Company, Gilead Sciences, Inc, and Roche Pharmaceuticals; and is a member of advisory boards for Bristol-Myers Squibb Company, Idenix Pharmaceuticals, Inc, Novartis Pharmaceuticals Corporation, Pharmasset, Roche Pharmaceuticals, and Vertex Pharmaceuticals Incorporated.

Michael W. Fried, MD, has received grant/research support from, is a consultant for, and is a member of advisory boards for GlaxoSmithKline, Idenix Pharmaceuticals Inc, Roche Pharmaceuticals, and Valeant Pharmaceuticals International.

Peer Reviewer has disclosed no significant relationships.

Projects In Knowledge's staff members have no significant relationships to disclose.

This CME/CE activity will include a discussion of the unlabeled/unapproved uses of hepatitis A vaccine, hepatitis B vaccine, a discussion of combination hepatitis A and B vaccine, interferon alfa-2a, and peginterferon alfa-2b.

Conflicts of interest are thoroughly vetted by the Executive Committee of Projects In Knowledge. All conflicts are resolved prior to the beginning of the activity by the Trust In Knowledge peer review process.

The opinions expressed in this activity are those of the faculty and do not necessarily reflect those of Projects In Knowledge.

This CME/CE activity is provided by Projects In Knowledge solely as an educational service. Specific patient care decisions are the responsibility of the clinician caring for the patient.


This independent CME/CE activity is supported by an educational grant from Bristol-Myers Squibb Company.
top

1765

 

 

Program Information

Faculty
Target Audience
Activity Goal
Learning Objectives
CME Information
Disclosure Information
Technical Requirements


By clicking below, I certify that I have read the accompanying CME/CE and disclosure information and am ready to continue to this activity.

View Webcast

Release Date: December 1, 2006.

Termination Date: December 1, 2007.

Estimated Time for Completion of this Activity: 1.0 hour.



Recommend this page
Recommend this to a colleague


This independent CME/CE activity is supported by an educational grant from Bristol-Myers Squibb Company.




ABOUT US  |  CONTACT US  |  CONTRACT  |  DIRECTIONS  |  PRIVACY POLICY  |  RESOURCES
Copyright © 1997-2017, Projects In Knowledge, Inc. All rights reserved.
PROJECTS IN KNOWLEDGE • Overlook at Great Notch • 150 Clove Road, 10th Floor • Little Falls, New Jersey 07424 (973) 890-8988